Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns
PhyCordPrem
Prospective Unblinded Randomized Controlled Study Assessing the Physiologically Based Cord Clamping on Ventilation Duration in Moderate and Late Preterm
1 other identifier
interventional
180
1 country
2
Brief Summary
Before birth, the baby's lungs are filled with fluid and babies do not use the lungs to breathe, as the oxygen comes from the placenta. As delivery approaches, the lungs begin to absorb the fluid. After vaginal delivery, the umbilical cord is clamped and cut after a delay that allows some of the blood in the umbilical cord and placenta to flow back into the baby. Meanwhile, as the baby breathes for the first time, the lungs fill with air and more fluid is pushed out. However, it does not always work out that way. A baby born prematurely may have breathing problems because of extra fluid staying in the lungs related to the immaturity of the lung structure. Thus, the baby must breathe quicker and harder to get enough oxygen enter into the lungs. The newborn is separated from the mother to provide emergency respiratory support. Although the baby is usually getting better within one or two days, the treatment requires close monitoring, breathing help, and nutritional help as the baby is too tired to suck and swallow milk. Sometimes, the baby cannot recover well and show greater trouble breathing needing intensive care. This further separates the mother and her baby. A possible mean to help the baby to adapt better after a premature birth while staying close to the mother is to delay cord clamping when efficient breathing is established, either spontaneously or after receiving breathing help at birth. In this study, we intend to test this procedure in moderate or late preterm infants and see whether the technique helps the baby to better adapt after birth and to better initiate a deep bond with the mother.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2024
CompletedStudy Start
First participant enrolled
February 19, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedMarch 5, 2024
March 1, 2024
1.9 years
January 11, 2024
March 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of non-invasive or invasive respiratory support.
from Birth to 28 days of life
Secondary Outcomes (25)
Rate of neonatal mortality
within 28 days of delivery
Rate of neonatal resuscitation
within first 10 minutes of life
Rate of neonatal respiratory morbidity
from Birth to 28 days of life
Number of admission to the NICU or special care baby unit
within first 72 hours of life
Length of hospitalization
Up to 8 weeks post delivery
- +20 more secondary outcomes
Study Arms (2)
Physiological Based Cord Clamping (PBCC)
EXPERIMENTALIn the intervention group, newborns will receive PBCC. The resuscitation table will be placed as close as possible to the mother's pelvis. Stabilization will start as soon as the infant is placed on the platform. The nurse will place the oximeter sensor on the right wrist, electrocardiogram electrodes on the chest of the newborn. Local resuscitation guidelines will be in respect of the Newborn Life support European Resuscitation Council 2021 guidelines. Stabilization of the newborn will be performed while the cord is intact and the cord will be clamped after respiratory stabilization will be achieved, de fined as the establishment of regular spontaneous breathing, a heart rate above 100 bpm and oxygen saturation by pulse oximetry above 85% while using supplemental oxygen less than 0,4. If the infant does not reach the criteria for being stable, the maximum clamping time will be 10 min. After clamping, the platform will be withdrawn and placed next to the bed of the mother.
Differed Cord Clamping (DCC)
ACTIVE COMPARATORIn the control group, newborns will receive standard DCC defined as time based and performed at 60 seconds after birth, depending on the clinical condition of the infant, in accordance with the ERC guidelines 2021.Then infants will be transferred to a standard resuscitation table located in a stabilization room next to the operating room. Further treatment and intervention required for cardiopulmonary stabilization will be provided on the standard resuscitation table. Stabilization will start as soon as the infant is placed on the resuscitation table. The nurse will place the oximeter sensor on the right wrist, ECG electrodes on the chest and temperature probe on the right hypochondrium of the newborn. Local resuscitation guidelines will be in respect of the Newborn Life support European Resuscitation Council 2021 guidelines. The time to reach the stabilisation described above (a HR above 100 bpm and SpO 2 above 85% while using supplemental oxygen less than 0,4) is recorded.
Interventions
Eligibility Criteria
You may qualify if:
- Pregnant women followed-up in Brugmann University Hospital will be eligible to participate if:
- The delivery takes place between 32 0/7 and 36 6/7 weeks of gestation
- They carry singletons
You may not qualify if:
- Fetal anomalies including congenital malformations, anemia, and growth restriction with abnormal Dopplers.
- Abnormal placentation such as placenta previa.
- Signs of fetal distress necessitating an emergency cesarean section.
- Maternal health issue including severe anemia (defined as hemoglobin level \< 7 g/dL), preeclampsia, and bleeding disorders.
- Maternal refusal of the use of blood products.
- General anesthesia for cesarian section.
- Planned cord blood banking.
- Total language barrier without possibility of translation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Queen Fabiola Children's University Hospitallead
- The Belgian Kids Fundcollaborator
- Fonds IRIS-Recherchecollaborator
- Ars Statisticacollaborator
Study Sites (2)
CHU Brugmann
Brussels, 1020, Belgium
Hôpital Universitaire Des Enfants Reine Fabiola
Brussels, 1020, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna AMORUSO
HUDERF
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2024
First Posted
February 28, 2024
Study Start
February 19, 2024
Primary Completion
January 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
March 5, 2024
Record last verified: 2024-03